Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2022 - PubMed (original) (raw)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2022

Neil Murthy et al. MMWR Morb Mortal Wkly Rep. 2022.

Abstract

At its November 2021 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2022. The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes to the cover page, tables, and notes from the 2021 immunization schedule.† In addition, the 2022 adult immunization schedule provides an appendix that lists the contraindications to and precautions for all routinely recommended vaccines in the schedule. This schedule can be found on the CDC immunization schedule website (https://www.cdc.gov/vaccines/schedules). Health care providers are advised to use the cover page, tables, notes, and appendix together. This adult immunization schedule is recommended by ACIP (https://www.cdc.gov/vaccines/acip) and approved by CDC (https://www.cdc.gov), the American College of Physicians (https://www.acponline.org), the American Academy of Family Physicians (https://www.aafp.org), the American College of Obstetricians and Gynecologists (https://www.acog.org), the American College of Nurse-Midwives (https://www.midwife.org), the American Academy of Physician Associates (https://www.aapa.org), and the Society for Healthcare Epidemiology of America (https://www.shea-online.org).

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Henry Bernstein reports that he is the editor of Current Opinion in Pediatrics Office Pediatrics Series and received a presentation honorarium from the Florida chapter of American Academy of Pediatrics. Veronica McNally reports that she is the president of the Franny Strong Foundation. Kevin Ault reports having received a grant from the National Cancer Institute, consulting fees from PathoVax, and payments supporting attending meetings and/or travel from the American College of Obstetricians and Gynecologists. In addition, Kevin Ault reports that he serves as a volunteer on the medical advisory board of Family Fighting Flu, and as a member of the infectious disease working group for the American College of Obstetricians and Gynecologists. No other potential conflicts of interest were disclosed.

Cited by

Diagnosis and Management of Hepatitis Delta Virus Infection.
Pan C, Gish R, Jacobson IM, Hu KQ, Wedemeyer H, Martin P. Pan C, et al. Dig Dis Sci. 2023 Aug;68(8):3237-3248. doi: 10.1007/s10620-023-07960-y. Epub 2023 Jun 20. Dig Dis Sci. 2023. PMID: 37338616 Free PMC article. Review.
Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn's disease in the USA.
Singer D, Thompson-Leduc P, Gupta D, Cheng WY, Poston S, Ma S, Pawlowski JE, Duh MS, Morris ED, Devine F, Farraye FA. Singer D, et al. Gastroenterol Rep (Oxf). 2023 Apr 12;11:goad016. doi: 10.1093/gastro/goad016. eCollection 2023. Gastroenterol Rep (Oxf). 2023. PMID: 37064550 Free PMC article.
Global burden of hepatitis B virus: current status, missed opportunities and a call for action.
Hsu YC, Huang DQ, Nguyen MH. Hsu YC, et al. Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):524-537. doi: 10.1038/s41575-023-00760-9. Epub 2023 Apr 6. Nat Rev Gastroenterol Hepatol. 2023. PMID: 37024566 Review.
The 2022 ACR vaccination guideline: a call-to-action.
Colmegna I, Libman M. Colmegna I, et al. Nat Rev Rheumatol. 2023 May;19(5):263-264. doi: 10.1038/s41584-023-00954-0. Nat Rev Rheumatol. 2023. PMID: 36973498 Free PMC article.
A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles.
Nakao R, Kobayashi H, Iwabuchi Y, Kawahara K, Hirayama S, Ramstedt M, Sasaki Y, Kataoka M, Akeda Y, Ohnishi M. Nakao R, et al. NPJ Vaccines. 2022 Nov 26;7(1):153. doi: 10.1038/s41541-022-00572-z. NPJ Vaccines. 2022. PMID: 36435869 Free PMC article.

References

1. CDC. Charter of the Advisory Committee on Immunization Practices. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://www.cdc.gov/vaccines/acip/committee/acip-charter.pdf
1. CDC: Advisory Committee on Immunization Practices (ACIP). ACIP Recommendations. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. Accessed January 25, 2022. https://www.cdc.gov/vaccines/acip/recommendations.html
1. Grohskopf LA, Alyanak E, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2021–22 influenza season. MMWR Recomm Rep 2021;70(RR-5):1–28. 10.15585/mmwr.rr7005a1 - DOI - PMC - PubMed
1. Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:109–17. 10.15585/mmwr.mm7104a1 - DOI - PMC - PubMed
1. Anderson TC, Masters NB, Guo A, et al. Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:80–4. 10.15585/mmwr.mm7103a2 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources

Full Text Sources

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2022 - PubMed (original) (raw)